CTLA4 and melanoma: At present, drugs for melanoma include small molecule inhibitors for BRAF or MEK, anti-CTLA4 antibody, anti-PD1 antibody, and modified oncolytic herpes virus talimogene laherparepvec (T-VEC) (Luke et al., 2017).